Foghorn Therapeutics Inc. (FHTX) Financial Statements (2026 and earlier)

Company Profile

Business Address 500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments80,87655,45480,33652,214101,13692,795
Cash and cash equivalent80,87655,45480,33652,214101,13692,795
Restricted cash and investments1,250     
Other undisclosed current assets81,109194,147159,845299,185358,42697,892
Total current assets:163,235249,601240,181351,399459,562190,687
Noncurrent Assets
Operating lease, right-of-use asset30,94922,64129,95634,08638,51642,804
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization      19,528
Restricted cash and investments2,0001,7081,7081,7081,7331,733
Other noncurrent assets4681,1152,3792,400842
Other undisclosed noncurrent assets1,9159,96412,95615,31117,563 
Total noncurrent assets:34,86834,38145,73553,48460,21264,907
TOTAL ASSETS:198,103283,982285,916404,883519,774255,594
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,62312,31615,36816,41513,38112,841
Accounts payable4,2663,7856,2605,4143,8193,680
Accrued liabilities11,3578,5319,10811,0019,5629,161
Deferred revenue43,19245,60634,55032,82028,3172,024
Other undisclosed current liabilities9239,0678,5185,9706,9943,981
Total current liabilities:59,73866,98958,43655,20548,69218,846
Noncurrent Liabilities
Long-term debt and lease obligation     51,33878,015
Long-term debt, excluding current maturities      19,654
Liabilities, other than long-term debt246,865262,521304,670349,566322,87312,546
Deferred revenue205,962234,457268,115304,000322,73012,546
Other liabilities556  29143 
Operating lease, liability40,34728,06436,55545,53751,33858,361
Total noncurrent liabilities:246,865262,521304,670349,566374,21190,561
Total liabilities:306,603329,510363,106404,771422,903109,407
Equity
Equity, attributable to parent(108,500)(45,528)(77,190)11296,871146,187
Common stock664444
Additional paid in capital523,937512,515395,196377,232361,133309,126
Accumulated other comprehensive income (loss)24135(826)(3,986)(10)(7)
Accumulated deficit(632,467)(558,184)(471,564)(373,138)(264,256)(162,936)
Total equity:(108,500)(45,528)(77,190)11296,871146,187
TOTAL LIABILITIES AND EQUITY:198,103283,982285,916404,883519,774255,594

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues30,90922,60234,15519,2282,500430
Sublease income  2,9002,6002,500 
Gross profit:30,90922,60234,15519,2282,500430
Operating expenses(117,298)(125,285)(142,061)(136,365)(102,053)(68,961)
Other undisclosed operating loss     (1,181) 
Operating loss:(86,389)(102,683)(107,906)(117,137)(100,734)(68,531)
Nonoperating income (expense)12,10616,06313,7068,255(586)(269)
Other nonoperating income    2,580  
Interest and debt expense     (1,233)(1,201)
Loss from continuing operations before income taxes:(74,283)(86,620)(94,200)(108,882)(102,553)(70,001)
Income tax expense   (4,226)   
Loss from continuing operations:(74,283)(86,620)(98,426)(108,882)(102,553)(70,001)
Loss before gain (loss) on sale of properties:✕✕✕✕✕(102,553)(70,001)
Other undisclosed net income      1,201
Net loss:(74,283)(86,620)(98,426)(108,882)(102,553)(68,800)
Other undisclosed net income attributable to parent     1,233 
Net loss available to common stockholders, diluted:(74,283)(86,620)(98,426)(108,882)(101,320)(68,800)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(74,283)(86,620)(98,426)(108,882)(102,553)(68,800)
Comprehensive loss:(74,283)(86,620)(98,426)(108,882)(102,553)(68,800)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(111)9613,160(3,976)1,230(7)
Comprehensive loss, net of tax, attributable to parent:(74,394)(85,659)(95,266)(112,858)(101,323)(68,807)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: